Azithromycin prophylaxis after lung transplant is associated with improved overall survival

Azithromycin prophylaxis (AP) in lung transplant recipients has been shown to reduce the composite endpoint of death or chronic lung allograft dysfunction (CLAD) onset but without a clear effect on overall survival. Our program began using AP in 2010. We sought to evaluate the association between AP and survival, the risk of CLAD and baseline lung allograft dysfunction (BLAD).

Source: The Journal of Heart and Lung Transplantation - September 15, 2020 Category: Transplant Surgery Authors: David Li, Qiuli Duan, Justin Weinkauf, Ali Kapasi, Rhea Varughese, Alim Hirji, Dale Lien, Steven Meyer, Bryce Laing, Jayan Nagendran, Kieran Halloran Tags: Original Clinical Science Source Type: research